Sneed Jr. v. AcelRx Pharmaceuticals, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION 6 AARON SNEED JR., Case No. 21-cv-04353-BLF
Plaintiff,
ORDER APPOINTING AARON SNEED
v. AND YAACOV MUSRY AS LEAD
PLAINTIFFS AND POMERANTZ LLP
ACELRX PHARMACEUTICALS, INC., et AS LEAD COUNSEL al., [Re: ECF Nos. 28, 33] Defendants. 12 Before the Court are two1 competing motions to appoint lead plaintiffs and lead counsel in this securities class action brought against AcelRx Pharmaceuticals, Inc., Vincent Angotti, and Raffi Asadorian over allegedly misleading statements made about AcelRx’s DSUIVA drug. The first motion is brought by putative lead plaintiffs Aaron Sneed and Yaacov Musry and their putative counsel Pomerantz LLP. ECF No. 28 (“S&M Motion”). The second is brought by putative lead plaintiff Paul Dupré and his putative counsel Roche Freedman LLP. ECF No. 33 (“Dupré Motion”). Each party has filed an opposition to the competing motion. ECF Nos. 36, 38. 20…